. The alternative method for determination of cardiac glycosides in blood has been the more time-consuming Rb method (4, 5) . During the past 10 years, RIA procedures have been widely discussed with reference to digoxin (6) (7) (8) (9) (10) (11) , but relatively few studies have been made with digitoxin (12) (13) (14) (15) .
Since 1969, our laboratory has used a modified Rb method (16) for routine clinical measurements and research work. Because of recent work with small children and dogs, where relatively small quantities of blood were available, we felt a need for a micromethod for the analysis of digitoxin. Thus, we investigated a micromethod 1251-RIA for the assay of digitoxin in serum, urine, and cerebrospinal fluid, and studied the interference of digoxin and other cardioactive digitoxin metabolites with the assay.
Materials and Method

Materials
The following were used for standard curves and replicate sample analysis in each matrix:
Plasma from a blood-bank pool. Urine from healthy volunteers. Cambridge, MA 02139) was used for the assay of all matrixes. Each sample was diluted 11-fold. We added 50 ILL of this standard solution to 1.0 mL of buffer, shook gently manually to mix the contents, and then incubated at room temperature for 15 mm, after which we added 0.1 mL of digitoxigenin solution. Each sample consisted of 100 ILL of serum, urine, CSF, or buffer and was diluted with 1 mL of buffer. Fifty microlitres of the diluted samples and 1 mL of buffer were added to polystyrene tubes coated with rabbit anti-digitoxin serum. We mixed the contents by gently shaking the racks before incu- bation at room temperature for 15 mm. A digitoxigenin derivative solution (0.1 mL) was then added to all tubes, which were next incubated in a water bath at 37 #{176}C for 45 mm. After aspirating the contents and rinsing twice with buffer solution, we counted the radioactivity with an Auto-Gamma scintillation spectrometer (Model 5210; Packard Instrument Co., Downers Grove, IL 60515). To prepare standard curves, we added 5, 10, 20, 30, 40, 50, and 100 ng of digitoxin to 1 mL of serum, urine, or CSF. The counts per minute (cpm) for 100 ng of digitoxin added to serum was chosen to express 100% reactivity in the assay. Percent changes from this value were used to characterize the reactivity of various digitoxin concentrations in various matrixes. The same proce4ure was followed in the investigation of digoxin and the other cardioactive metabolites of digitoxin that were added to buffer before analysis.
To assess accuracy within each series for the three matrixes, we analyzed 10 replicate samples within the following concentration ranges: 0-5, 5-10, 10-20, 20-30 , and 30-40 ig/L. Table 1 gives the accuracy of digitoxin measurements within defined concentration ranges. The coefficient of variation (CV) is <10% when the digitoxin concentration exceeds 5 g/L. The precision for determinations in serum and CSF is similar, but analysis of urine yields larger CV's. The reactivity with the assay depends on the nature of the matrix; e.g., serum and buffer have a higher reactivity than urine and CSF (Table 2) . Digitoxin has seven cardioactive metabolites that interfere with the assay to various extents. The digitoxosides of digitoxin show a high reactivity with the assay, whereas digoxigenin reacts only about half as much as digitoxin.
Results
On the other hand, digoxin, its digitoxosides, and digoxigenin hardly react at all.
Discussion
We tested this radioimmunoassay with the aim of applying the procedure to samples obtained from children, neurologic patients, and dogs, where sample size is restricted. Accuracy is adequate when digitoxin concentrations exceed 5 g/L; below this range a larger sample will be necessary. Further, the nature of the matrix is an important factor determining the reactivity with the assay. Use of standard curves based on serum samples for analysis of urine or CSF samples, for example, would lead to serious underestimates of digitoxin concentrations of 10 fLg/L or more. Because information on the matrix used in preparing the standard curve is often lacking in publications on clinical investigations, interpretation of results is difficult. One of us has reported similar findings for a modified Rb method (5, 17) in regard to urineand bile-based standard curves.
The responses given by the active drug metabolites in an assay is also pertinent for interpretation of results from #{232}linical studies. All cardioactive metabolites react in the Rb method, but to various extents (18) . Our present investigation has shown a high reactivity of the two digitoxosides of digitoxin and a reduced activity for the genin. Digoxin is a metabolite of digitoxin, but in the present radioimmunoassay there is hardly any reaction with digoxin or with its hydrolyzed derivatives (DG-2, DG-1, and DG-0).
We conclude that this assay is simple to use and accurate, but the samples from various body fluids need to be analyzed with a standard curve from the same matrix. Cross reactivity with digoxin presents no problem.
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